{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:38:48Z","timestamp":1773117528811,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08640-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:24:45Z","timestamp":1768353885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of dextromethorphan\/quinidine in treating pseudobulbar affect in neurological disorders: A systematic review and dose-classified network meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5653-1931","authenticated-orcid":false,"given":"Muneeb Ahmad","family":"Muneer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irra","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eeshal","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaila Sharmin","family":"Saaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muhammad Nasir Abbas","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-4874","authenticated-orcid":false,"given":"Amogh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ijlal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"6","key":"8640_CR1","first-page":"325","volume":"38","author":"MP Cruz","year":"2013","unstructured":"Cruz MP (2013) Nuedexta for the treatment of pseudobulbar affect: a condition of involuntary crying or laughing. PT 38(6):325\u2013328","journal-title":"PT"},{"key":"8640_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2147\/NDT.S30713","volume":"10","author":"KA Schoedel","year":"2014","unstructured":"Schoedel KA, Morrow SA, Sellers EM (2014) Evaluating the safety and efficacy of dextromethorphan\/quinidine in the treatment of pseudobulbar affect. Neuropsychiatr Dis Treat 10:1161\u20131174. https:\/\/doi.org\/10.2147\/NDT.S30713","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"43","key":"8640_CR3","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LD, Fran\u00e7ois R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen TL, Miller E, Bache SM, M\u00fcller K, Ooms J, Robinson D, Seidel DP, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H (2019) Welcome to the tidyverse. J Open Source Softw 4(43):1686. https:\/\/doi.org\/10.21105\/joss.01686","journal-title":"J Open Source Softw"},{"issue":"2","key":"8640_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i02","volume":"106","author":"S Balduzzi","year":"2023","unstructured":"Balduzzi S, R\u00fccker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O, Schwarzer G (2023) Netmeta: an R package for network Meta-Analysis using frequentist methods. J Stat Softw 106(2):1\u201340. https:\/\/doi.org\/10.18637\/jss.v106.i02","journal-title":"J Stat Softw"},{"issue":"5","key":"8640_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ana.22093","volume":"68","author":"EP Pioro","year":"2010","unstructured":"Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, Hepner A, Kaye R, Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators (2010) Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol 68(5):693\u2013702. https:\/\/doi.org\/10.1002\/ana.22093","journal-title":"Ann Neurol"},{"issue":"5","key":"8640_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.20828","volume":"59","author":"HS Panitch","year":"2006","unstructured":"Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A, Psuedobulbar Affect in Multiple Sclerosis Study Group (2006) Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 59(5):780\u20137. https:\/\/doi.org\/10.1002\/ana.20828","journal-title":"Ann Neurol"},{"issue":"8","key":"8640_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1212\/01.wnl.0000142042.50528.2f","volume":"63","author":"BR Brooks","year":"2004","unstructured":"Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, Pope LE, Smith RA, AVP-923 ALS Study Group (2004) Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial. Neurology 63(8):1364\u20131370. https:\/\/doi.org\/10.1212\/01.wnl.0000142042.50528.2f","journal-title":"Neurology"},{"issue":"1","key":"8640_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0609-0","volume":"16","author":"FM Hammond","year":"2016","unstructured":"Hammond FM, Alexander DN, Cutler AJ, D\u2019Amico S, Doody RS, Sauve W, Zorowitz RD, Davis CS, Shin P, Ledon F, Yonan C, Formella AE, Siffert J (2016) PRISM II: an open-label study to assess effectiveness of dextromethorphan\/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurol 16(1):89. https:\/\/doi.org\/10.1186\/s12883-016-0609-0","journal-title":"BMC Neurol"},{"issue":"10","key":"8640_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.pmrj.2018.02.010","volume":"10","author":"FM Hammond","year":"2018","unstructured":"Hammond FM, Sauve W, Ledon F, Davis C, Formella AE (2018) Safety, tolerability, and effectiveness of Dextromethorphan\/Quinidine for pseudobulbar affect among study participants with traumatic brain injury: results from the PRISM-II open label study. PM R 10(10):993\u20131003. https:\/\/doi.org\/10.1016\/j.pmrj.2018.02.010","journal-title":"PM R"},{"issue":"1","key":"8640_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-014-0018-5","volume":"3","author":"EP Pioro","year":"2014","unstructured":"Pioro EP (2014) Review of dextromethorphan 20\u00a0mg\/quinidine 10\u00a0mg (NUEDEXTA(\u00ae)) for pseudobulbar affect. Neurol Ther 3(1):15\u201328. https:\/\/doi.org\/10.1007\/s40120-014-0018-5","journal-title":"Neurol Ther"},{"issue":"5","key":"8640_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/11207260-000000000-00000","volume":"25","author":"KP Garnock-Jones","year":"2011","unstructured":"Garnock-Jones KP (2011) Dextromethorphan\/quinidine: in pseudobulbar affect. CNS Drugs 25(5):435\u2013445. https:\/\/doi.org\/10.2165\/11207260-000000000-00000","journal-title":"CNS Drugs"},{"key":"8640_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120726","volume":"451","author":"M Tahedl","year":"2023","unstructured":"Tahedl M, Tan EL, Siah WF, Hengeveld JC, Doherty MA, McLaughlin RL, Hardiman O, Finegan E, Bede P (2023) Radiological correlates of pseudobulbar affect: corticobulbar and cerebellar components in primary lateral sclerosis. J Neurol Sci 451:120726. https:\/\/doi.org\/10.1016\/j.jns.2023.120726","journal-title":"J Neurol Sci"},{"issue":"3","key":"8640_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00415-008-0685-1","volume":"255","author":"O Ghaffar","year":"2008","unstructured":"Ghaffar O, Chamelian L, Feinstein A (2008) Neuroanatomy of pseudobulbar affect: a quantitative MRI study in multiple sclerosis. J Neurol 255(3):406\u2013412. https:\/\/doi.org\/10.1007\/s00415-008-0685-1","journal-title":"J Neurol"},{"key":"8640_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/DNND.S34160","volume":"3","author":"RR King","year":"2013","unstructured":"King RR, Reiss JP (2013) The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration. Degenerative Neurol Neuromuscul Disease 3:23\u201331. https:\/\/doi.org\/10.2147\/DNND.S34160","journal-title":"Degenerative Neurol Neuromuscul Disease"},{"issue":"4 Suppl 5","key":"8640_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/s1092852900025979","volume":"12","author":"PV Rabins","year":"2007","unstructured":"Rabins PV, Arciniegas DB (2007) Pathophysiology of involuntary emotional expression disorder. CNS Spectr 12(4 Suppl 5):17\u201322. https:\/\/doi.org\/10.1017\/s1092852900025979","journal-title":"CNS Spectr"},{"issue":"12","key":"8640_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1136\/jnnp.2005.073288","volume":"77","author":"H Kosaka","year":"2006","unstructured":"Kosaka H, Omata N, Omori M, Shimoyama T, Murata T, Kashikura K, Takahashi T, Murayama J, Yonekura Y, Wada Y (2006) Abnormal pontine activation in pathological laughing as shown by functional magnetic resonance imaging. J Neurol Neurosurg Psychiatry 77(12):1376\u20131380. https:\/\/doi.org\/10.1136\/jnnp.2005.073288","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"8640_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2004.08.004","volume":"28","author":"S Hesse","year":"2004","unstructured":"Hesse S, Barthel H, Schwarz J, Sabri O, M\u00fcller U (2004) Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev 28(6):547\u2013563. https:\/\/doi.org\/10.1016\/j.neubiorev.2004.08.004","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"8640_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2165\/00023210-200822070-00001","volume":"22","author":"HS Wortzel","year":"2008","unstructured":"Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB (2008) Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22(7):531\u2013545. https:\/\/doi.org\/10.2165\/00023210-200822070-00001","journal-title":"CNS Drugs"},{"issue":"7","key":"8640_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1586\/ern.11.68","volume":"11","author":"A Miller","year":"2011","unstructured":"Miller A, Pratt H, Schiffer RB (2011) Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Rev Neurother 11(7):1077\u20131088. https:\/\/doi.org\/10.1586\/ern.11.68","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"8640_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO;2-Z","volume":"14","author":"A Burns","year":"1999","unstructured":"Burns A, Russell E, Stratton-Powell H, Tyrell P, O\u2019Neill P, Baldwin R (1999) Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry 14(8):681\u2013685","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"8640_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jocn.2011.07.006","volume":"19","author":"RR King","year":"2012","unstructured":"King RR, Reiss JP (2012) Treatment of pseudobulbar affect with citalopram in a patient with progressive multifocal leukoencephalopthy. J Clin Neuroscience: Official J Neurosurgical Soc Australasia 19(1):185\u2013186. https:\/\/doi.org\/10.1016\/j.jocn.2011.07.006","journal-title":"J Clin Neuroscience: Official J Neurosurgical Soc Australasia"},{"issue":"23","key":"8640_CR22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM198506063122303","volume":"312","author":"RB Schiffer","year":"1985","unstructured":"Schiffer RB, Herndon RM, Rudick RA (1985) Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 312(23):1480\u20131482. https:\/\/doi.org\/10.1056\/NEJM198506063122303","journal-title":"N Engl J Med"},{"issue":"4","key":"8640_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4140\/TCP.n.2014.264","volume":"29","author":"E Patatanian","year":"2014","unstructured":"Patatanian E, Casselman J (2014) Dextromethorphan\/quinidine for the treatment of pseudobulbar affect. Consultant Pharmacist: J Am Soc Consultant Pharmacists 29(4):264\u2013269. https:\/\/doi.org\/10.4140\/TCP.n.2014.264","journal-title":"Consultant Pharmacist: J Am Soc Consultant Pharmacists"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08640-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:02:45Z","timestamp":1773072165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8640"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08640-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare to have no conflicts of interests relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Ethical approval for the study was not required as publicly available data was used, and anonymity was maintained throughout the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no financial interests relevant to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of financial interests"}},{"value":"The authors declare no non-financial interests relevant to this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of non-financial interests"}},{"value":"Not applicable, as this study does not report a clinical trial.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration details\/number"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research registry number"}},{"value":"Human consent was not required as publicly available data was used, and anonymity was maintained throughout the study.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Generative AI tools, including Paperpal and ChatGPT-4o, were utilized solely for language refinement, grammar enhancement, and stylistic refinements. These tools had no role in conceptualization, data analysis, interpretation of results, or substantive content development. All intellectual contributions, data analysis, and scientific interpretations remain solely the work of the authors. The final manuscript was critically reviewed and edited to ensure accuracy and originality. The authors take full responsibility for the integrity of the work presented.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI use statement"}}],"article-number":"159"}}